Author:
Rouse Richard JD,Field Katrine,Lapira Jennifer,Lee Allen,Wick Ivan,Eckhardt Colleen,Bhasker C Ramana,Soverchia Laura,Hardiman Gary
Abstract
Abstract
Background
Successful microarray experimentation requires a complex interplay between the slide chemistry, the printing pins, the nucleic acid probes and targets, and the hybridization milieu. Optimization of these parameters and a careful evaluation of emerging slide chemistries are a prerequisite to any large scale array fabrication effort. We have developed a 'microarray meter' tool which assesses the inherent variations associated with microarray measurement prior to embarking on large scale projects.
Findings
The microarray meter consists of nucleic acid targets (reference and dynamic range control) and probe components. Different plate designs containing identical probe material were formulated to accommodate different robotic and pin designs. We examined the variability in probe quality and quantity (as judged by the amount of DNA printed and remaining post-hybridization) using three robots equipped with capillary printing pins.
Discussion
The generation of microarray data with minimal variation requires consistent quality control of the (DNA microarray) manufacturing and experimental processes. Spot reproducibility is a measure primarily of the variations associated with printing. The microarray meter assesses array quality by measuring the DNA content for every feature. It provides a post-hybridization analysis of array quality by scoring probe performance using three metrics, a) a measure of variability in the signal intensities, b) a measure of the signal dynamic range and c) a measure of variability of the spot morphologies.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference18 articles.
1. Marton MJ, DeRisi JL, Bennett HA, Iyer VR, Meyer MR, Roberts C, Stoughton R, Burchard J, Slade D, Dai H, Bassett DE, Hartwell LH, Brown PO, Friend SH: Drug target validation and identification of secondary drug target effects using DNA microarrays. Nature Med. 1998, 4: 1293-1301. 10.1038/3282.
2. Hardiman G: Microarrays Technologies 2006: an overview. Pharmacogenomics. 2006, 8: 1153-1158. 10.2217/14622416.7.8.1153.
3. Bowtell DDL: Options available – from start to finish for obtaining expression data by microarray. Nature Genetics. 1999, 21: 25-32. 10.1038/4455.
4. Rouse R, Verdun K, Hardiman G: DNA microarrays and the core facility. Microarray Methods and Applications. Edited by: Hardiman G. 2003, DNA Press Inc., Eagleville, PA, 3: 37-66.
5. Chandrasekharappa S, Holloway A, Iyer V, Monte D, Murphy M, Nowak NJ: Generation of probes for spotted microarrays. DNA Microarrays: A Molecular Cloning Manual. Edited by: Bowtell D, Sambrook J. 2003, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1-60.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献